Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-240.94%
operating margin TTM
-238.06%
revenue TTM
7.38 Million
revenue per share TTM
0.13$
valuation ratios | |
|---|---|
| pe ratio | -0.76 |
| peg ratio | -0.04 |
| price to book ratio | 0.58 |
| price to sales ratio | 2.05 |
| enterprise value multiple | -1.22 |
| price fair value | 0.58 |
profitability ratios | |
|---|---|
| gross profit margin | 67.97% |
| operating profit margin | -238.06% |
| pretax profit margin | -241.15% |
| net profit margin | -240.94% |
| return on assets | -39.71% |
| return on equity | -65.62% |
| return on capital employed | -42.55% |
liquidity ratio | |
|---|---|
| current ratio | 5.62 |
| quick ratio | 5.62 |
| cash ratio | 5.24 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 35.14 |
| days of payables outstanding | 71.11 |
| cash conversion cycle | -35.97 |
| receivables turnover | 10.39 |
| payables turnover | 5.13 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.32 |
| debt equity ratio | 0.61 |
| long term debt to capitalization | 0.38 |
| total debt to capitalization | 0.38 |
| interest coverage | -5,749.91 |
| cash flow to debt ratio | -0.73 |
cash flow ratios | |
|---|---|
| free cash flow per share | -7.36 |
| cash per share | 10.82 |
| operating cash flow per share | -6.16 |
| free cash flow operating cash flow ratio | 1.20 |
| cash flow coverage ratios | -0.73 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -5.11 |
Frequently Asked Questions
When was the last time Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) reported earnings?
Ginkgo Bioworks Holdings, Inc. (DNA) published its most recent earnings results on 12-11-2024.
What is Ginkgo Bioworks Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)'s trailing twelve months ROE is -65.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ginkgo Bioworks Holdings, Inc. (DNA) currently has a ROA of -39.71%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did DNA's net profit margin stand at?
DNA reported a profit margin of -240.94% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is DNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.62 in the most recent quarter. The quick ratio stood at 5.62, with a Debt/Eq ratio of 0.61.